Home / Going-concern warnings / GENELUX Corp
Filed 2025-08-07 路 Form 10-Q 路 Accession 0001641172-25-022583 micro
Price before filing: $3.59 (2025-08-06 close, split/dividend-adjusted)
Market cap at flag: $126.6M (2025-08-07) 路 Latest: $108.8M (2026-10-16)
| Window | GNLX | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -0.8% | +2.5% | -3.4% | 2025-09-08 |
| 90 days | +118.4% | +7.4% | +111.0% | 2025-11-05 |
| 180 days | -24.2% | +9.6% | -33.8% | 2026-02-03 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 5 insiders sold $78K (5 sales)
30 days after: 1 insider sold $6K (2 sales)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-05-12 | Cappello Joseph VP, Pharmaceutical Development | Sale | 4,737 | $2.92 | $14K | no | Form 4 |
| 2025-05-12 | Ryder Sean General Counsel | Sale | 4,475 | $2.92 | $13K | no | Form 4 |
| 2025-05-12 | Smalling Ralph Head of Regulatory | Sale | 1,259 | $2.92 | $4K | no | Form 4 |
| 2025-05-12 | Yu Yong VP, Clinical Trial Operations | Sale | 5,579 | $2.92 | $16K | no | Form 4 |
| 2025-05-12 | Zindrick Thomas President and CEO, Director | Sale | 10,764 | $2.92 | $31K | no | Form 4 |
| 2025-08-07: red flag filed | |||||||
| 2025-08-21 | Smalling Ralph Head of Regulatory | Sale | 1,244 | $3.36 | $4K | no | Form 4 |
| 2025-09-03 | Smalling Ralph Head of Regulatory | Sale | 580 | $3.36 | $2K | no | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-09 to 2025-09-06. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"These factors raise substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-06-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.